CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 252 enrolled
Drug / intervention
Xpert MRSA/SA SSTI +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01523899
NCT01523899N/ACompleted
CompareCT.gov

A Randomized Clinical Trial Comparing Use of Rapid Molecular Testing for Staphylococcus Aureus for Patients With Cutaneous Abscesses in the Emergency Department With Standard of Care.

George Washington University·interventional·Posted Feb 1, 2012·Updated Sep 6, 2017

In Brief

A clinical study evaluating Xpert MRSA/SA SSTI and Standard culture for Cutaneous Abscess. Completed, enrolled 252 participants across 2 sites.

Detailed Summary

This study expands upon pilot data for feasibility since May 2011. The study aims to evaluate the effect of rapid test availability on use of targeted spectrum antibiotics for non-MRSA abscesses in ambulatory patients in the Emergency Department (ED). The multi-institutional study will assess the feasibility of providing the GeneXpert® MRSA/SA SSTI assay to the ED and evaluate the impact of delivering the test result to clinicians in real-time on patient management decisions regarding the use of antimicrobial agents. Patients are randomized to standard culture (control arm) or to the GeneXpert® assay plus standard culture.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCutaneous Abscess
CountriesUnited States
CollaboratorsJohns Hopkins University

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 1, 2012
Enrollment StartMay 1, 2011
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 14.4 years ago

Interventions

Xpert MRSA/SA SSTIdevice

Use of Xpert MRSA/SA SSTI assay

Standard cultureother